Reaction Details |
| Report a problem with these data |
Target | Vasopressin V1b receptor |
---|
Ligand | BDBM50338796 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_727040 (CHEMBL1686964) |
---|
IC50 | 34±n/a nM |
---|
Citation | Napier, SE; Letourneau, JJ; Ansari, N; Auld, DS; Baker, J; Best, S; Campbell-Wan, L; Chan, JH; Craighead, M; Desai, H; Goan, KA; Ho, KK; Hulskotte, EG; MacSweeney, CP; Milne, R; Morphy, JR; Neagu, I; Ohlmeyer, MH; Peeters, AW; Presland, J; Riviello, C; Ruigt, GS; Thomson, FJ; Zanetakos, HA; Zhao, J; Webb, ML Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists. Bioorg Med Chem Lett21:1871-5 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Vasopressin V1b receptor |
---|
Name: | Vasopressin V1b receptor |
Synonyms: | AVPR V1b | AVPR V3 | AVPR1B | AVPR3 | Antidiuretic hormone receptor 1b | V1BR_HUMAN | V1bR | VASOPRESSIN V1B | VPR3 | Vasopressin V1b receptor | Vasopressin V1b receptor (V1b) | Vasopressin V3 | Vasopressin V3 receptor |
Type: | Enzyme |
Mol. Mass.: | 46985.01 |
Organism: | Homo sapiens (Human) |
Description: | P47901 |
Residue: | 424 |
Sequence: | MDSGPLWDANPTPRGTLSAPNATTPWLGRDEELAKVEIGVLATVLVLATGGNLAVLLTLG
QLGRKRSRMHLFVLHLALTDLAVALFQVLPQLLWDITYRFQGPDLLCRAVKYLQVLSMFA
STYMLLAMTLDRYLAVCHPLRSLQQPGQSTYLLIAAPWLLAAIFSLPQVFIFSLREVIQG
SGVLDCWADFGFPWGPRAYLTWTTLAIFVLPVTMLTACYSLICHEICKNLKVKTQAWRVG
GGGWRTWDRPSPSTLAATTRGLPSRVSSINTISRAKIRTVKMTFVIVLAYIACWAPFFSV
QMWSVWDKNAPDEDSTNVAFTISMLLGNLNSCCNPWIYMGFNSHLLPRPLRHLACCGGPQ
PRMRRRLSDGSLSSRHTTLLTRSSCPATLSLSLSLTLSGRPRPEESPRDLELADGEGTAE
TIIF
|
|
|
BDBM50338796 |
---|
n/a |
---|
Name | BDBM50338796 |
Synonyms: | CHEMBL1684559 | N-cyclopropyl-2-(2-(3-methoxyphenyl)-6-(3-morpholinopropoxy)-4-oxoquinazolin-3(4H)-yl)acetamide |
Type | Small organic molecule |
Emp. Form. | C27H32N4O5 |
Mol. Mass. | 492.5668 |
SMILES | COc1cccc(c1)-c1nc2ccc(OCCCN3CCOCC3)cc2c(=O)n1CC(=O)NC1CC1 |
Structure |
|